solution by MARKET

GMP-Compliant Pharmaceutical Turnkey Solutions & Equipment for Iraq

With multiple pharmaceutical plants delivered in Iraq and 40+ turnkey projects worldwide, IVEN is your proven partner for building world-class production facilities in the Iraqi market.

Market Overview

A Clear View of the Local Market Landscape

Iraq’s pharmaceutical market is worth between $3.5–$4 billion and is expanding rapidly. The market is projected to grow at a CAGR of 7.2% during 2026–2032. Due to decades of conflict, domestic production dropped significantly, making Iraq heavily reliant on imports — with more than 90% of drugs sourced from other countries. This creates strong demand for localized pharmaceutical manufacturing equipment and turnkey plant solutions.

Market Demand

Demand Trends Within the Country

  • Local Manufacturing Capacity

    Iraq is transitioning from heavy import dependency toward gradual localization and structured procurement-led growth — creating urgent need for new production facilities.
  • GMP-Compliant Facilities

    Regulatory authorities are slowly adopting more stringent GMP and track-and-trace requirements, forcing an industry-wide upgrade in compliance.
  • IV Solution & Essential Medicine Production

    The Iraqi government is investing heavily in hospitals, healthcare centers, and pharmaceuticals to rebuild the sector after conflict.
  • Turnkey Engineering Partners

    Buyers need full-scope partners who can deliver from plant design through commissioning — most local companies lack the engineering infrastructure to self-build.

Our Local Expertise

Local Experience, Reliable Execution

  • In Iraq, we have assisted multiple clients in establishing pharmaceutical plants, contributing to the advancement of Iraq’s healthcare sector.

  • We’ve provided hundreds of sets of pharmaceutical equipment to more than 60 countries and delivered turnkey projects in the USA, Saudi Arabia, Iraq, Nigeria, Indonesia, and more.

  • 60+ proprietary technology patents with full in-house manufacturing across four owned factories covering filling lines, water treatment, and intelligent logistics.

  • All equipment engineered to meet EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP — the standards Iraq’s regulators increasingly reference.

Recommended Products

Selected Products for This Market

Compliance & Logistics

Meeting Local Standards with Reliable Delivery

Compliance & Certification

  • All equipment complies with EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP — fully aligned with SFDA GMP inspection requirements

  • Complete IQ/OQ/PQ validation documentation packages provided for streamlined SFDA facility approval and GMP licensing

  • Engineering designs support Vision 2030 localization targets and NUPCO guaranteed offtake procurement eligibility

Logistics & Delivery

  • Direct shipping from four owned manufacturing bases in China to Iraqi ports (Umm Qasr/Basra) or overland via Turkey/Jordan.

  • Dedicated engineering teams deployed on-site for installation, commissioning, and operator training.

  • Flexible payment terms including irrevocable L/C at sight and T/T — compatible with KIMADIA and private sector procurement.

case

Success Snapshot

  • Pharmaceutical Manufacturer

    Iraq

    IVEN delivered complete IV solution production equipment and provided full engineering support for facility establishment. The plant was built to WHO GMP standards, enabling the client to produce essential infusion products domestically for the first time.

  • Healthcare Enterprise

    Middle East

    A client from Saudi Arabia ordered a complete Soft Bag IV-Solution Turnkey Project capable of producing more than 22 million soft bags yearly. The project demonstrated IVEN’s ability to deliver large-scale turnkey plants across the Middle East region.

testimony

Trusted by Local Customers

  • “IVEN understood the regulatory landscape and delivered a production-ready facility that met both our quality standards and tight timeline. Their on-site team was professional and responsive throughout.”

    Mr. A

    General Manager

  • “We evaluated multiple European and Chinese suppliers before choosing IVEN. Their turnkey capability and competitive pricing made them the clear choice for our IV solution plant.”

    Mr. B

    Director of Operations

Support

FAQ

Yes. We have assisted multiple clients in Iraq with establishing pharmaceutical plants, and Iraq is one of our key turnkey project markets in the Middle East.

All equipment meets EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP — fully aligned with the standards Iraq’s Ministry of Health requires for manufacturer registration.

Yes. We provide all required documentation including GMP certificates, CPP, validation reports, and technical specifications formatted for public and private procurement processes.

Absolutely. We deploy dedicated engineering teams for installation, commissioning, staff training, and IQ/OQ/PQ validation at your facility.

Depending on project scope, a standard IV solution turnkey plant typically takes 12–18 months from contract signing to production-ready commissioning.

Related Market Solutions